From efficacy to impact: An advocate's agenda for HIV pre-exposure prophylaxis implementation

American Journal of Preventive Medicine

Volumn 44, Issue 1 SUPPL. 2, 2013, Pages

  Warren, Mitchell J ^a   Bass, Emily S ^a  

^a AVAC: Global Advocacy for HIV Prevention   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONDOM; DRUG APPROVAL; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; PROPHYLAXIS; SEXUAL BEHAVIOR; TREATMENT RESPONSE;

EID: 84871769814     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.10.006     Document Type: Note

References (41)

1. R.M. Grant, L.R. Lama, P.L. Anderson Preexposure chemoprophylaxis for HIV prevention in men who have sex with Men N Engl J Med 363 27 2010 2587 2599
2. J.M. Baeten, D. Donnell, P. Ndase Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 5 2012 399 410
3. M.C. Thigpen, P.M. Kebaabetswe, L.A. Paxton Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 5 2012 423 434
4. R.C. Bailey, S. Moses, C.B. Parker Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial Lancet 369 9562 2007 643 656
5. R.H. Gray, G. Kigozi, D. Serwadda Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial Lancet 369 9562 2007 657 666
6. M.S. Cohen, Y.Q. Chen, M. McCauley Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 6 2011 493 505
7. S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 23 2009 2209 2220
8. A.K. Quarraisha, S.S. Abdool Karim, J.A. Frohlich Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 5996 2010 1168 1174
9. FDA News release: FDA approves first drug for reducing the risk of sexually acquired HIV infection www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm312210.htm 16 Jul 2012
10. D.K. Smith, J.W. Dearing, T. Sanchez, R.H. Goldschmidt Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S. Am J Prev Med 44 1S2 2013 S59 S62
11. J.D. Campbell, J.H. Herbst, R.T. Koppenhaver Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV Am J Prev Med 44 1S2 2013 S63 S69
12. J.W. Dearing, D.K. Smith, R.S. Larson, C.A. Estabrooks Designing for diffusion of a biomedical intervention Am J Prev Med 44 1S2 2013 S70 S76
13. W.E. Norton, R.S. Larson, J.W. Dearing Primary care and public health partnerships for implementing pre-exposure prophylaxis Am J Prev Med 44 1S2 2013 S77 S79
14. S.E. Cohen, A.Y. Liu, K.T. Bernstein, S. Philip Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis Am J Prev Med 44 1S2 2013 S80 S85
15. E.J. Edelman, D.A. Fiellin Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine Am J Prev Med 44 1S2 2013 S86 S90
16. M.K. ElZarrad, E.T. Eckstein, R.E. Glasgow Applying chronic illness care, implementation science, and self-management support to HIV Am J Prev Med 44 1S2 2013 S99 S107
17. M.W. Thrun Provider-initiated HIV-risk behavior counseling in the context of HIV pre-exposure prophylaxis Am J Prev Med 44 1S2 2013 S108 S111
18. C.K. Malotte Brief risk-reduction counseling in clinical settings for HIV pre-exposure prophylaxis Am J Prev Med 44 1S2 2013 S112 S118
19. S.G. Hosek HIV pre-exposure prophylaxis diffusion and implementation issues in nonclinical settings Am J Prev Med 44 1S2 2013 S129 S132
20. H.H. Tilson Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings Am J Prev Med 44 1S2 2013 S151 S155
21. D.K. Smith, J. Beltrami A proposed framework to monitor daily oral antiretroviral pre-exposure prophylaxis in the U.S. Am J Prev Med 44 1S2 2013 S141 S146
22. S. Trent-Adams, L.W. Cheever Providing HIV pre-exposure prophylaxis: lessons learned from the Ryan White HIV/AIDS program Am J Prev Med 44 1S2 2013 S147 S150
23. L. Culp, L. Caucci State adolescent consent laws and implications for HIV pre-exposure prophylaxis Am J Prev Med 44 1S2 2013 S119 S124
24. M. Horberg, B. Raymond Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance Am J Prev Med 44 1S2 2013 S125 S128
25. M.J. Dutta Disseminating HIV pre-exposure prophylaxis information in underserved communities Am J Prev Med 44 1S2 2013 S133 S136
26. S. Philpott Social justice, public health ethics, and the use of HIV pre-exposure prophylaxis Am J Prev Med 44 1S2 2013 S137 S140
27. J.W. Dearing, W.E. Norton, R.S. Larson Next steps in designing for diffusion of pre-exposure prophylaxis: demonstration projects Am J Prev Med 44 1S2 2013 S156 S160
28. L.J. Koenig, C. Lyles, D.K. Smith Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies Am J Prev Med 44 1S2 2013 S91 S98
29. M.G. Fowler, M.A. Lampe, D.J. Jamieson, A.P. Kourtis, M.F. Rogers Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions Am J Obstet Gynecol 197 3S 2007 S3 S9
30. M. Warren, A. Philpott Expanding safer sex options: introducing the female condom into national programmes Reprod Health Matters 11 21 2003 130 139
31. CDC Antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services MMWR Recomm Rep 54 RR-2 2005 1 20
32. B. Mathers HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage Lancet 375 9719 2010 1014 1028
33. AVAC, National Empowerment Network of People Living with HIV/AIDS in Kenya, Sonke Gender Justice Network, Uganda Network of AIDS Service Organizations A Call to Action on Voluntary Medical Male Circumcision 2012 www.avac.org/ht/a/GetDocumentAction/i/44846
34. Clinicaltrials.gov Bethesda (MD): National Institute of Allergy and Infectious Diseases (US). Identifier NCT01632995, Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease Clinics; 2012 Sep 23 www.clinicaltrials.gov/ct2/show/NCT01632995?term=NCT01632995.&rank=1
35. California HIV/AIDS Research Program Press Release: UC launches initiative to test an HIV prevention pill in California www. californiaaidsresearch.org/initiatives-programs/epidemic-interv-pressrel.html 17 Apr 2012
36. CDC Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men MMWR Morb Mortal Wkly Rep 60 3 2011 65 68
37. CDC Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults MMWR Morb Mortal Wkly Rep 61 31 2012 586 589
38. AVAC PrEP: Roadmap to the real world www.avac.org/ht/a/GetDocumentAction/ i/38018 August 2011
39. AIDS.gov 12 cities project blog.aids.gov/wp-content/uploads/NHAS-HHS-12. pdf 2011
40. The White House Office of National AIDS Policy National HIV/AIDS Strategy for the United States www.aids.gov/federal-resources/policies/national-hiv- aids-strategy/nhas.pdf 2010
41. H.I. Hall, E.L. Frazier, P. Rhodes Continuum of HIV care: differences in care and treatment by sex and race/ethnicity in the United States. Proceedings of the International AIDS Conference; 2012 Jul 22-27; Washington DC pag.aids2012.org/Abstracts.aspx?SID=13&AID=21098